Cancer test provider Natera is in a buy zone above a cup base ahead of second-quarter results due Thursday. The post Natera Eyes Massive New Cancer Market; In Buy Zone With Q2 Report Due appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real